These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6361960)

  • 1. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends.
    Cross A; Allen JR; Burke J; Ducel G; Harris A; John J; Johnson D; Lew M; MacMillan B; Meers P
    Rev Infect Dis; 1983; 5 Suppl 5():S837-45. PubMed ID: 6361960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of infections due to Pseudomonas aeruginosa.
    Morrison AJ; Wenzel RP
    Rev Infect Dis; 1984; 6 Suppl 3():S627-42. PubMed ID: 6443765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving epidemiology of Pseudomonas aeruginosa infections.
    Cross AS
    Eur J Clin Microbiol; 1985 Apr; 4(2):156-9. PubMed ID: 3891336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial infections in an Iranian burn care center.
    Lari AR; Alaghehbandan R
    Burns; 2000 Dec; 26(8):737-40. PubMed ID: 11024608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
    Fournier A; Voirol P; Krähenbühl M; Bonnemain CL; Fournier C; Pantet O; Pagani JL; Revelly JP; Dupuis-Lozeron E; Sadeghipour F; Pannatier A; Eggimann P; Que YA
    Burns; 2016 May; 42(3):564-70. PubMed ID: 26708236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience at a university and review of the literature.
    John JF; Twitty JA
    Rev Infect Dis; 1986; 8(5):693-704. PubMed ID: 3538313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.
    Høiby N; Pedersen SS
    Antibiot Chemother (1971); 1989; 42():124-9. PubMed ID: 2596835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa].
    Ono Y
    Nihon Rinsho; 2002 Nov; 60(11):2150-5. PubMed ID: 12440121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
    Driscoll JA; Brody SL; Kollef MH
    Drugs; 2007; 67(3):351-68. PubMed ID: 17335295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of protein typing in molecular epidemiological investigation of nosocomial infection outbreak of aminoglycoside-resistant Pseudomonas aeruginosa.
    Song M; Tang M; Ding Y; Wu Z; Xiang C; Yang K; Zhang Z; Li B; Deng Z; Liu J
    Environ Sci Pollut Res Int; 2018 Aug; 25(23):22437-22445. PubMed ID: 29249031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.
    Tablan OC; Martone WJ; Jarvis WR
    Eur J Epidemiol; 1987 Dec; 3(4):336-42. PubMed ID: 3319668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa cross-infection in cystic fibrosis.
    Jones AM; Webb AK; Govan JR; Hart CA; Walshaw MJ
    Lancet; 2002 Feb; 359(9305):527-8. PubMed ID: 11853828
    [No Abstract]   [Full Text] [Related]  

  • 18. Keeping an eye on P. aeruginosa.
    Salter SJ
    Nat Rev Microbiol; 2015 Feb; 13(2):69. PubMed ID: 25549963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiologic study of pathogens causing nosocomial infections].
    Chang SC; Chen YC; Hsu LY
    J Formos Med Assoc; 1990 Nov; 89(11):1023-30, 1015. PubMed ID: 1982123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran.
    Faraji F; Mahzounieh M; Ebrahimi A; Fallah F; Teymournejad O; Lajevardi B
    Microb Pathog; 2016 Oct; 99():1-4. PubMed ID: 27457974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.